MOUNJARO
MOUNJARO
Approved
DIN Number
02532921
Drug Class
Human
Market Date
N/A
Company
HC
eli lilly canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02532921
AIG Number0164301004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BX16 TIRZEPATIDE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.06
Health Canada Classification
ACTIVE INGREDIENTS (1)
TIRZEPATIDEActive
Strength: 10 MG / 0.5 ML
Monograph: TIRZEPATIDE